Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Sodium Thiosulfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fennec Pharma Starts Cancer Study at Univ. of Arizona
    Fennec Pharma Starts Cancer Study at Univ. of Arizona

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3268978/0/en/Fennec-Pharmaceuticals-Announces-Investigator-Sponsored-Study-to-Be-Conducted-by-University-of-Arizona-Cancer-Center.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Swissmedic Approves PEDMARQSI to Prevent Kids' Hearing loss
    Swissmedic Approves PEDMARQSI to Prevent Kids' Hearing loss

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/norgine-announces-swissmedic-approval-of-pedmarqsi-for-the-prevention-of-cisplatin-induced-hearing-loss-in-children-302725193.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share
    Fennec Pharma Resolves PEDMARK Patent Litigation With Settlement
    Fennec Pharma Resolves PEDMARK Patent Litigation With Settlement

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256242/0/en/Fennec-Pharmaceuticals-Announces-Settlement-Agreement-Resolving-PEDMARK-Patent-Litigation.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Fennec Pharma Partners With Tampa General Cancer Institute
    Fennec Pharma Partners With Tampa General Cancer Institute

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249229/0/en/Fennec-Pharmaceuticals-Announces-Clinical-Research-Collaboration-with-Tampa-General-Hospital-Cancer-Institute.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Fennec Pharma Announces Trial for Metastatic TGCT at City of Hope
    Fennec Pharma Announces Trial for Metastatic TGCT at City of Hope

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202214/0/en/Fennec-Pharmaceuticals-Announces-Investigator-Sponsored-Trial-to-Be-Conducted-by-City-of-Hope-in-Metastatic-Testicular-Germ-Cell-Tumors.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Fennec Pharma Reports PEDMARK Study Success In Japan
    Fennec Pharma Reports PEDMARK Study Success In Japan

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197763/0/en/Fennec-Pharmaceuticals-Announces-Positive-Topline-Results-From-Investigator-Initiated-Clinical-Study-of-PEDMARK-in-Japan-to-Reduce-Cisplatin-Induced-Hearing-Loss.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.